Completed PHASE3 INTERVENTIONAL 2-arm NCT02402101

Effect of the Transcranial Direct Current Stimulation on the Dopaminergic Transmission in Healthy Subjects (DOPA-STIM)

Effect of the Transcranial Direct Current Stimulation on the Dopaminergic

Sponsor: Hôpital le Vinatier

Conditions Dopamine Transcranial Direct Current Stimulation

Interventions Procedure: active tDCS Procedure: sham tDCS

Updated 7 times since 2017 Last updated: Aug 22, 2016 Started: Feb 28, 2015 Primary completion: Aug 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Dopamine and Transcranial Direct Current Stimulation, this trial is completed. The trial is conducted by Hôpital le Vinatier and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hôpital le Vinatier

Data source: Hôpital le Vinatier

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bron, France